CD4 and tuberculosis: IDSA guidelines suggest initiation of ART within the first two weeks of starting anti-TB treatment in patients with CD4 counts < 50 cells/mm3 and within the first eight weeks to the rest except those having TB of the central nervous system, where ART should be further delayed [7].